FDA Draft Guidance on the use of electronic Informed Consent

A Q&A guide on the use of electronic Informed Consent in Clinical Investigations

This guidance provides recommendations for clinical investigators, sponsors, and institutional review boards (IRBs) on the use of electronic media and processes to obtain informed consent for FDA-regulated clinical investigations of medical products, including human drug and biological products, medical devices, and combinations thereof.

Read the pdf
Copyright Widler & Schiemann AG 2015. All Rights Reserved. /